Abstract
For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.
Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles
Current Cancer Drug Targets
Title: Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives
Volume: 11 Issue: 2
Author(s): I. Ali
Affiliation:
Keywords: Nano anti-cancer drugs, pros and cons, toxicities, special features, future perspectives, immune system, micelles, dendrimers, micro-capsules, multidrug resistance, chemotherapy, paclitaxel, tumor, dendritic cells, neutropenia, thrombocytopenia, serum transaminase levels, gadolinium, fibrosis, synergistic efficacy, Deoxyribo nucleic acid, Interferon-, Inter Leukin-6, Inter Leukin-12, Multi drug resistance, Poly ethylene glycol, Red blood corpuscles, Small interfering ribo nucleic acids, Tumor necrosis factor, White blood corpuscles
Abstract: For the last one decade, scientists are working at developing nano anti-cancer drugs with the claim of ideal ones due to their targeted chemotherapic nature. These drugs have many beneficial properties such as targeted drug delivery and gene therapy modalities with minimum side effects. This article describes pros and cons and future perspectives of nano anti-cancer drugs. Efforts have been made to address the importance, special features, toxicities (general, blood identities, immune system and environmental) and future perspectives of nano anti-cancer drugs. It was concluded that nano anti-cancer drugs may be magic bullet drugs for cancer treatments leading to a bright future of the whole world.
Export Options
About this article
Cite this article as:
Ali I., Nano Anti-Cancer Drugs: Pros and Cons and Future Perspectives, Current Cancer Drug Targets 2011; 11 (2) . https://dx.doi.org/10.2174/156800911794328457
DOI https://dx.doi.org/10.2174/156800911794328457 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Call for Papers in Thematic Issues
Advances in Cancer Biomarkers and Potential Drug Targets: From Diagnosis to Therapy
Cancer biomarkers play a crucial role in the diagnosis, prognosis, and treatment of cancer. They provide valuable information for cancer detection, risk assessment, treatment selection, and monitoring response to therapy. With advancements in molecular biology and high-throughput technologies, there has been an increasing interest in identifying and characterizing cancer biomarkers ...read more
Novel Therapeutic Approaches to Target Drug Resistant Tumors
With the development of disciplines such as chemical biology and molecular biology, the genes or proteins closely related to tumor occurrence and development have gradually become clear. Targeted therapies targeting these genes or proteins provide more effective methods for tumor treatment. Tumor targeted drugs generally only act on specific targets ...read more
ROLE OF IMMUNE AND GENOTOXIC RESPONSE BIOMARKERS IN TUMOR MICROENVIRONMENT IN CANCER DIAGNOSIS AND TREATMENT
Biological biomarkers have been used in medical research as an indicator of a normal or abnormal process inside the body, or of a disease. Nowadays, various researchers are in process to explore and investigate the biological markers for the early assessment of cancer. DNA Damage response (DDR) pathways and immune ...read more
Targeting the battlefield between host and tumor: basic research and clinical practice on reshaping tumor immune microenvironment
Immune system protects host against malignant tumors through effector cells and molecules. Cancer development and its response to therapy are regulated by inflammation, which either promotes or suppresses cancer progression. Chronic inflammation facilitates cancer progression and treatment resistance, whereas induction of acute inflammatory reactions often lead to anti-cancer immune responses. ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Headache: One of the Most Common and Troublesome Adverse Reactions to Drugs
Current Drug Safety Pharmacotherapy of Abdominal Aortic Aneurysms
Current Vascular Pharmacology Drug Withdrawal and Hyperphagia: Lessons from Tobacco and Other Drugs
Current Pharmaceutical Design Nutraceuticals: Beyond the Diet Before the Drugs
Current Bioactive Compounds Normal Ventricular Functional Reference Parameters on Magnetic Resonance Imaging in Healthy Children
Current Medical Imaging ACE2 and Diabetic Complications
Current Pharmaceutical Design Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry The Role of Anti-Inflammatory Drugs in Respiratory Diseases - Pirfenidone, Penicillamine, Chloroquine and Chlorambucil
Current Respiratory Medicine Reviews Pharmacogenetics in Cardiovascular Antithrombotic Therapy
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Effects of Tea Catechins on Inflammation-Related Cardiovascular Diseases
Current Immunology Reviews (Discontinued) Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets Circulatory Estrogen Level Protects Against Breast Cancer in Obese Women
Recent Patents on Anti-Cancer Drug Discovery Evaluating Oxidative Stress in Human Cardiovascular Disease: Methodological Aspects and Considerations
Current Medicinal Chemistry The Critical Role of Toll-Like Receptor Signaling Pathways in the Induction and Progression of Autoimmune Diseases
Current Molecular Medicine Cellular Cardiomyoplasty – Challenges of a New Era
Current Tissue Engineering (Discontinued) Toxics of Tobacco Smoke and Cardiovascular System: From Functional to Cellular Damage
Current Pharmaceutical Design Recent Advances in Image-Based Stem-Cell Labeling and Tracking, and Scaffold-Based Organ Development in Cardiovascular Disease
Recent Patents on Medical Imaging In-Vitro and In-Vivo Pharmacological Activities with Phytochemical Evaluation of Methanolic Extract of Microcos paniculata Stem Barks
Current Drug Therapy Neurocognitive Monitoring and Care During Pediatric Cardiopulmonary Bypass — Current and Future Directions
Current Cardiology Reviews Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation
Current Drug Targets